Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
about
Genome-Wide Association Study of Polymorphisms Predisposing to BronchiolitisChallenges and opportunities in developing respiratory syncytial virus therapeuticsAdherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations.Respiratory Syncytial Virus Infection in High-risk Infants - an Update on Palivizumab ProphylaxisContribution of respiratory tract infections to child deaths: a data linkage study.Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review.Respiratory syncytial virus-associated mortality in hospitalized infants and young children.Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.Clinical characterisation and phylogeny of respiratory syncytial virus infection in hospitalised children at Red Cross War Memorial Children's Hospital, Cape Town.Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)Clinical Decision Support and Palivizumab: A Means to Protect from Respiratory Syncytial VirusMucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels.Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applicationsRetrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases.Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.Repurposing staples for viruses: applying peptide design to RSV prophylaxis.Viral infections and the development of asthma in children.Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infectionA New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World.Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants.Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain.Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study 1.Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis on Bronchiolitis Hospitalizations among High-risk Infants.Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.Letters to the Editor.Eligibility for palivizumab prophylaxis in a cohort of children with severe bronchiolitis.The prevention of respiratory syncytial virus infection.Respiratory syncytial virüs infections in neonates and infantsRespiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis
P2860
Q29248034-F1BC8AD7-3E46-43F1-9285-D0BE50BD7C58Q30300567-3B36CBC3-DAD6-4161-9DD1-169ACD75336CQ33705088-DF5CBBAE-8B46-450D-B3B4-4C8FEB9CFCC4Q34049590-F0763270-4F5F-480F-8203-B371C6531671Q34587026-935BE444-6B4D-44F7-A08F-A37FD32F54F0Q34726169-D171BCC1-CAFB-450D-AC2B-2F31A556F1E4Q34785440-33967693-001B-4906-8EC2-13E42F066F63Q35952327-96D1892D-EDE0-48BD-A56D-CD15CEFE523EQ36035788-9A496EE5-8A61-4F71-B7FE-A2203A91A9EFQ36376822-A50C79A7-3DF5-4380-B937-D34DA15635C1Q36434174-67B3C6F0-9995-48E5-A34F-BB70F31CE4E8Q36438581-0253C772-AB57-4E9B-A583-F9B6E007B955Q36665634-E262CBC1-5AAD-48E6-A634-4789178B181EQ36739674-9243ED5F-F0B6-45D0-BD41-C0C6B7929941Q37177598-30212623-7212-48E5-9AE7-5D9363B00581Q37318542-F022017A-B92C-48FB-96DC-369721394B21Q37591891-AD555F85-22E8-48D0-B4E5-8173715E0CCAQ37725351-C8D4B61F-076B-4074-B040-A0023A26F795Q37726694-181CC887-AA74-460A-B1F0-C11028B98EB2Q38244136-E7E1F917-610C-4BE0-B0A7-75A1E5BCFE6DQ38671952-45A1200A-AC84-4381-AC79-9D07ABC4D531Q40082914-FCA78EF9-5750-47DA-9F12-66DE7A0995F9Q40696627-65D106CD-3E00-4A3D-937B-6CA83BA807FAQ41989828-1132CCBB-61EC-4202-980A-655A6C2E027EQ45324366-1FC24387-7B6C-4FD4-82E0-83DF52397CBBQ47112273-45E9186B-EBC1-4E97-B501-F23150FF1C72Q47132154-26D0BD6D-435D-42BD-BEC4-6C29E6323F26Q47551236-A38FA701-D79F-466E-AEF0-B5095DA55EE9Q49474232-950DFAC5-57D8-451A-B52B-5BA3D56DDAF8Q51558042-534729C3-9F5C-4F35-9822-9892620633EDQ51579784-3E959671-7518-4709-850F-0B1D767C5565Q55645905-69EA11D0-35F4-41CF-8436-398B4D7E4543Q56379720-8FD83174-CE8E-4C21-87E3-02E66F5953C5Q58084597-80D7202F-B357-41B5-9FF8-F59D7AF0ADB9
P2860
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Monoclonal antibody for reduci ...... al virus infection in children
@ast
Monoclonal antibody for reduci ...... al virus infection in children
@en
Monoclonal antibody for reduci ...... al virus infection in children
@en-gb
Monoclonal antibody for reduci ...... al virus infection in children
@nl
type
label
Monoclonal antibody for reduci ...... al virus infection in children
@ast
Monoclonal antibody for reduci ...... al virus infection in children
@en
Monoclonal antibody for reduci ...... al virus infection in children
@en-gb
Monoclonal antibody for reduci ...... al virus infection in children
@nl
prefLabel
Monoclonal antibody for reduci ...... al virus infection in children
@ast
Monoclonal antibody for reduci ...... al virus infection in children
@en
Monoclonal antibody for reduci ...... al virus infection in children
@en-gb
Monoclonal antibody for reduci ...... al virus infection in children
@nl
P2093
P2860
P3181
P1476
Monoclonal antibody for reduci ...... al virus infection in children
@en
P2093
Jason W Nickerson
Juan David Rueda
Maria Ximena Rojas-Reyes
Tea Andabaka
Vesna Bacic Vrca
P2860
P3181
P356
10.1002/14651858.CD006602.PUB4
P50
P577
2013-04-30T00:00:00Z